These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34321413)

  • 21. Public Health Detailing for Human Immunodeficiency Virus Pre-exposure Prophylaxis.
    Ard KL; Edelstein ZR; Bolduc P; Daskalakis D; Gandhi AD; Krakower DS; Myers JE; Keuroghlian AS
    Clin Infect Dis; 2019 Feb; 68(5):860-864. PubMed ID: 30020422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods and Approaches to HIV Prevention.
    Balthazar MS
    J Assoc Nurses AIDS Care; 2017; 28(1):19-24. PubMed ID: 27751633
    [No Abstract]   [Full Text] [Related]  

  • 23. Factors associated with knowledge of pre-exposure prophylaxis in pregnant women in Cape Town, South Africa.
    DiTullio DJ; Farley E; Gomba Y; Coates TJ; Bekker LG; Myer L; Joseph Davey DL
    Int J STD AIDS; 2019 Oct; 30(11):1063-1070. PubMed ID: 31462164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.
    Sullivan PS; Giler RM; Mouhanna F; Pembleton ES; Guest JL; Jones J; Castel AD; Yeung H; Kramer M; McCallister S; Siegler AJ
    Ann Epidemiol; 2018 Dec; 28(12):833-840. PubMed ID: 30037634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring Gender Differences in PrEP Interest Among Individuals Testing HIV Negative in an Urban Emergency Department.
    Ridgway J; Almirol E; Schmitt J; Bender A; Anderson G; Leroux I; McNulty M; Schneider J
    AIDS Educ Prev; 2018 Oct; 30(5):382-392. PubMed ID: 30332310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
    Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Providers PrEP: Identifying Primary Health care Providers' Biases as Barriers to Provision of Equitable PrEP Services.
    Hull SJ; Tessema H; Thuku J; Scott RK
    J Acquir Immune Defic Syndr; 2021 Oct; 88(2):165-172. PubMed ID: 34506359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of HIV pre-exposure prophylaxis during the preconception, antepartum and postpartum periods at two United States medical centers.
    Seidman DL; Weber S; Timoney MT; Oza KK; Mullins E; Cohan DL; Wright RL
    Am J Obstet Gynecol; 2016 Nov; 215(5):632.e1-632.e7. PubMed ID: 27448959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults.
    Mullins TLK; Zimet G; Lally M; Xu J; Thornton S; Kahn JA
    AIDS Patient Care STDS; 2017 Dec; 31(12):504-516. PubMed ID: 29211514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding PrEP Persistence: Provider and Patient Perspectives.
    Laborde ND; Kinley PM; Spinelli M; Vittinghoff E; Whitacre R; Scott HM; Buchbinder SP
    AIDS Behav; 2020 Sep; 24(9):2509-2519. PubMed ID: 32048078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-exposure Prophylaxis Knowledge and Use Among Men Who Have Sex With Men in a Small Metropolitan Region of the Southeastern United States.
    Griffin JA; Eldridge-Smith ED; Yohannan J; Stepleman LM
    J Assoc Nurses AIDS Care; 2020; 31(1):80-91. PubMed ID: 31433361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unlocking HIV Pre-Exposure Prophylaxis Delivery: Examining the Role of HIV Providers in Pre-Exposure Prophylaxis Care.
    Kenison TC; Badenhop B; Safo S
    AIDS Patient Care STDS; 2020 Jun; 34(6):251-258. PubMed ID: 32484745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection--New York, 2012-2015.
    Laufer FN; O'Connell DA; Feldman I; ; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1296-301. PubMed ID: 26606257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-exposure prophylaxis in the era of pre-exposure prophylaxis: a study of post-exposure prophylaxis use in South-East Queensland since the Pharmaceutical Benefits Scheme listing of pre-exposure prophylaxis.
    Biggs K; O'Sullivan M; Palmer C; McLellan J; Marple-Clark F; Spinks A; Langton-Lockton J; Thng C
    Int J STD AIDS; 2020 Apr; 31(5):426-431. PubMed ID: 32192371
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention.
    Reidy M; Gardiner E; Pretorius C; Glaubius R; Torjesen K; Kripke K
    PLoS One; 2019; 14(6):e0218710. PubMed ID: 31242240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptance of HIV pre-exposure prophylaxis (PrEP) referral among a sample of PrEP-eligible emergency department patients.
    Faryar KA; Braun R; Ancona RM; Freiermuth C; Lyons MS
    Am J Emerg Med; 2022 Oct; 60():152-155. PubMed ID: 35973343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection.
    Tracer H; Jasmin W
    Am Fam Physician; 2019 Nov; 100(10):637-638. PubMed ID: 31730313
    [No Abstract]   [Full Text] [Related]  

  • 38. HIV Preexposure Prophylaxis in the Time of COVID-19: How a Robust and Responsive HIV Preexposure Prophylaxis Intervention Can Avert Loss of HIV Prevention Coverage During a Global Pandemic.
    Saberi P; Ming K; Hojilla JC; Scott HM; Neilands TB
    J Acquir Immune Defic Syndr; 2021 May; 87(1):e173-e176. PubMed ID: 33534275
    [No Abstract]   [Full Text] [Related]  

  • 39. What qualities in a potential HIV pre-exposure prophylaxis service are valued by black men who have sex with men in London? A qualitative acceptability study.
    Witzel TC; Nutland W; Bourne A
    Int J STD AIDS; 2018 Jul; 29(8):760-765. PubMed ID: 29466919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-exposure prophylaxis access in federally qualified health centers across 11 United States metropolitan statistical areas.
    Tookes H; Yao K; Chueng T; Butts S; Karsner R; Duque M; Cardenas G; Feaster DJ; Doblecki-Lewis S
    Int J STD AIDS; 2019 Sep; 30(10):978-984. PubMed ID: 31284842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.